ARCHIVES

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

This article is from The Cancer Letter archive.

Vol. 03 No. 02 | January 14, 1977

Download PDF Visit The Full Archive

Related Articles

In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers

October 4, 1996

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

RTOG Finds Twice A Day Radiation For Advanced Head And Neck Cancer Improved Local Tumor Control Rate

August 25, 2000

Duke’s Victor Dzau Named President of The Institute of Medicine

February 21, 2014

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

NCI Advisory Group, Other Cancer Meetings

August 16, 1985